Demin Yu

Shanghai, 200025, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications

HBV activates hepatic stellate cells through RUNX2/ITGBL1 axis.

HBV activates hepatic stellate cells through RUNX2/ITGBL1 axis.

Journal: Virology journal
Published: February 05, 2025

Serum O-glycosylated HBsAg levels correlate with HBV RNA in HBeAg positive CHB patients during antiviral therapy.

Serum O-glycosylated HBsAg levels correlate with HBV RNA in HBeAg positive CHB patients during antiviral therapy.

Journal: Antiviral research
Published: November 20, 2024

Risk predictive model for the development of hepatocellular carcinoma before initiating long-term antiviral therapy in patients with chronic hepatitis B virus infection.

Risk predictive model for the development of hepatocellular carcinoma before initiating long-term antiviral therapy in patients with chronic hepatitis B virus infection.

Journal: Journal of medical virology
Published: May 07, 2024

Spatial transcriptomics reveals a low extent of transcriptionally active hepatitis B virus integration in patients with HBsAg loss.

Spatial transcriptomics reveals a low extent of transcriptionally active hepatitis B virus integration in patients with HBsAg loss.

Journal: Gut
Published: July 04, 2023

Chimeric antigen receptors of HBV envelope proteins inhibit hepatitis B surface antigen secretion.

Chimeric antigen receptors of HBV envelope proteins inhibit hepatitis B surface antigen secretion.

Journal: Gut
Published: June 20, 2023

Hepatitis B virus middle surface antigen loss promotes clinical variant persistence in mouse models.

Hepatitis B virus middle surface antigen loss promotes clinical variant persistence in mouse models.

Journal: Virulence
Published: November 05, 2021

Viral quasispecies quantitative analysis: a novel approach for appraising the immune tolerant phase of chronic hepatitis B virus infection.

Viral quasispecies quantitative analysis: a novel approach for appraising the immune tolerant phase of chronic hepatitis B virus infection.

Journal: Emerging microbes & infections
Published: April 19, 2021

Serum Levels of ITGBL1 as an Early Diagnostic Biomarker for Hepatocellular Carcinoma with Hepatitis B Virus Infection.

Serum Levels of ITGBL1 as an Early Diagnostic Biomarker for Hepatocellular Carcinoma with Hepatitis B Virus Infection.

Journal: Journal of hepatocellular carcinoma
Published: February 18, 2021

Peg-interferon alpha add-on Tenofovir disoproxil fumarate achieved more HBsAg loss in HBeAg-positive chronic hepatitis B naïve patients.

Peg-interferon alpha add-on Tenofovir disoproxil fumarate achieved more HBsAg loss in HBeAg-positive chronic hepatitis B naïve patients.

Journal: Journal of viral hepatitis
Published: February 12, 2021

Variations in SARS-CoV-2 Spike Protein Cell Epitopes and Glycosylation Profiles During Global Transmission Course of COVID-19.

Variations in SARS-CoV-2 Spike Protein Cell Epitopes and Glycosylation Profiles During Global Transmission Course of COVID-19.

Journal: Frontiers in immunology
Published: May 24, 2020

An integrated software for virus community sequencing data analysis.

An integrated software for virus community sequencing data analysis.

Journal: BMC genomics
Published: February 12, 2020

ITGBL1 promotes cell migration and invasion through stimulating the TGF-β signalling pathway in hepatocellular carcinoma.

ITGBL1 promotes cell migration and invasion through stimulating the TGF-β signalling pathway in hepatocellular carcinoma.

Journal: Cell proliferation
Published: October 25, 2019
Showing 1-12 of 21

Last Updated: 09/26/2026